If you're on a GLP-1 fat loss journey
and something feels off β
stalled fat loss, extreme fatigue, nausea,
food aversions, or muscle loss β
this episode is for you.
Nearly 15% of the U.S. population is now on a GLP-1,
yet by research, over 90% are making the same mistake:
choosing weekly semaglutide over daily liraglutide
without understanding how human behavior, metabolism,
and muscle retention actually work.
In this episode, I break down:
β Why humans always choose the path of least resistance
(and why doctors prescribe weekly shots)
β The real difference between semaglutide vs. liraglutide
β Why weekly dosing causes more nausea, fatigue,
food aversion, and training drop-off
β How semaglutide increases risk of lean muscle loss
and metabolic slowdown
β Why daily liraglutide provides smoother appetite
and glucose control
β How half-life impacts hunger, energy, and adherence
β Why extreme appetite suppression backfires long-term
β How GLP-1s should be used to support training
and protein intake β not replace them
GLP-1s are powerful tools β
but when used incorrectly, they create the exact
rebound weight gain, metabolic damage, and frustration
women are trying to avoid.
If you want my full GLP-1 Micro-Dosing Blueprint β
including injection schedules, best practices,
workouts, and nutrition:
π DM me "GLP-1 MICRO DOSING BLUEPRINT"
on Instagram @DylanAConrad